AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests
July 29, 2020 08:26 ET
|
Anpac Bio, USA
SAN JOSE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Completed 1st Half Year with Increased ASP and Revenue
July 13, 2020 08:40 ET
|
Anpac Bio, USA
SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening
June 26, 2020 08:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Launches New Immunology Test Product Line
June 22, 2020 08:46 ET
|
Anpac Bio, USA
SAN JOSE, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening
June 19, 2020 08:46 ET
|
Anpac Bio, USA
SAN JOSE, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening
June 19, 2020 08:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Announces Appointment of New Chief Financial Officer
June 02, 2020 17:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States
May 26, 2020 08:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019
May 18, 2020 08:30 ET
|
Anpac Bio, USA
Continued annual revenue growthNumber of commercial CDA (cancer differentiation analysis)-based tests increased 26.0% year-on-yearContinued to gain customers and increase the acceptance of our cancer...
AnPac Files Its Annual Report on Form 20-F
May 18, 2020 08:24 ET
|
Anpac Bio, USA
SAN JOSE, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the United...